Clinical trial
Effects of Serotonin Transporter Inhibition on the Subjective Response to LSD in Healthy Subjects
NCT05175430 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Serotonin Transporter Inhibition on the Subjective Response to LSD in Healthy Subjects
- Lead sponsor
- University Hospital, Basel, Switzerland
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- October 24, 2022
- Completion date
- March 7, 2024
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy